Developing a lung cancer screening program for hospitalized patients.
Official title: Inpatient Capture: A Mixed Methods Study to Develop an Inpatient Lung Cancer Screening Program in a Safety Net Hospital.
Run by Physician Affiliate Group of New York · NCT06876831 · Data updated 2026-11-12
This study is trying to set up a lung cancer screening program for hospitalized patients aged 50-80 who have a history of smoking to help them get screened and quit smoking.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 80 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Physician Affiliate Group of New York Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | March 10, 2025 |
| Main results expected | September 10, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | March 14, 2025 |
| Trial ID | NCT06876831 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 50-80 with a history of smoking of 20 pack years or more, who are currently smoking or have quit within the last 15 years.
✕Probably not a fit
Patients under 50 or over 80 years of age, those with less than a 20 pack year smoking history, or who quit smoking more than 15 years ago may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to create an inpatient lung cancer screening program at a safety net hospital to address disparities in lung cancer mortality. It will utilize mixed methods, including shared decision-making and inpatient tobacco cessation counseling, to improve the uptake of lung cancer screening among high-risk patients. The program targets individuals aged 50-80 with a significant smoking history, focusing on those who are currently smoking or have recently quit. By integrating screening with tobacco cessation services, the study seeks to enhance patient outcomes and reduce barriers to care.
Why it matters
Potential benefit: If successful, this program could significantly reduce lung cancer mortality among high-risk populations by increasing access to screening and cessation services.
How similar studies have gone: Other studies have shown success in implementing lung cancer screening programs, particularly in high-risk populations, indicating that this approach has potential.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 50-80 years of age * greater than or equal to 20 pack year history * currently smoking or have quit within the last 15 years Exclusion Criteria: * \< 50 years of age, \> 80 years of age * \< 20 pack year history * quit smoking greater than 15 years
Where it's running
-
Metropolitan Hospital/ NYCHHC
New York, New York, United States Recruiting
Study contacts
- Study coordinator: Natoushka Trenard, MD, MPH
- Email: trenardn@nychhc.org
- Phone: 9548025735
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using AI to identify and prevent smoking-related diseases
This study is testing a new AI tool to see if it can help find and tell the difference between harmful and harmless lung nodules in smokers and former smokers over 50 who are at high risk for lung cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.